Please log in for more information
The distinct stages of Lyme disease progression can mimic other diseases, leading to misdiagnosis and failed treatment. Gold Standard Diagnostics is driven to continuously develop new diagnostic methods to tackle this challenge.
GSD’s first innovation was their Lyme Line Blot (Immunoblot) which has increased sensitivity and specificity for consistent, easy-to-interpret results. GSD is also concurrently expanding with additional innovations in Lyme ELISA algorithms and Tick-borne diagnostics.
As the market leader in Lyme, Gold Standard Diagnostics continues to push the diagnostic market forward with a comprehensive portfolio for all Lyme and Tick-borne testing needs.
